DOCTORAL NETWORK
PLASMA MEDICINE AGAINST
ACTINIC KERATOSIS

New cases per year are estimated
in germany
0
Every second European citizen has
developed an actinic keratosis by age 60
0
Up to 25% of European adults are believed to have at least one actinic keratosis
0
About PlasmACT

What is PlasmACT?

PlasmACT is a Marie Skłodowska-Curie Doctoral Network coordinated by the Leibniz Institute for Plasma Research and Technology in Greifswald, Germany, in collaboration with four other academic partners:
University Medical Center Rostock, Germany,
Eindhoven University of Technology, The Netherlands,
Centre national de la recherche scientifique, France and
University of Antwerp, Belgium.

In addition to our partners, our project also includes eight associated industry partners and two NGOs.

Our mission is to explore the potential of medical gas plasma technology in treating Actinic Keratosis, a common skin condition that can lead to skin cancer.

Latest News

Here you will find our latest news about our doctoral network PlasmACT.

October 16, 2024

Kick-Off Meeting

Our first project meeting took place in Greifswald where our team of doctoral candidates, academic partners, and industry collaborators came together.

More…

July 4, 2024

Article in "Leibniz-Nordost" Magazine

PlasmACT in the journal Leibniz Nordost, in which the five Leibniz institutions in the state of Mecklenburg-Vorpommern report.

More…

May 5, 2023

Article in the "Deutsches Ärzteblatt"

The article „Dermatology: Plasma research against actinic keratosis funded“ was published in the „Deutsches Ärzteblatt“

More…

Nach oben scrollen